0001383099-13-000004.txt : 20130927 0001383099-13-000004.hdr.sgml : 20130927 20130927140648 ACCESSION NUMBER: 0001383099-13-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20130927 DATE AS OF CHANGE: 20130927 EFFECTIVENESS DATE: 20130927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protagenic Therapeutics Inc. CENTRAL INDEX KEY: 0001383099 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-203658 FILM NUMBER: 131119244 BUSINESS ADDRESS: STREET 1: 149 5TH AVENUE, SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 1-416-500-3305 MAIL ADDRESS: STREET 1: 149 5TH AVENUE, SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Protagenic Therapeutics Inc DATE OF NAME CHANGE: 20061208 D 1 primary_doc.xml X0707 D LIVE 0001383099 Protagenic Therapeutics Inc. 149 5TH AVENUE, SUITE 500 NEW YORK NY NEW YORK 10010 1-416-500-3305 DELAWARE Protagenic Therapeutics Inc Corporation true Garo Armen c/o Protagenic Therapeutics, Inc. 149 5th Avenue, Suite 500 New York NY NEW YORK 10010 Director Khalil Barrage c/o Protagenic Therapeutics, Inc. 149 5th Avenue, Suite 500 New York NY NEW YORK 10010 Director Hartoun Hartounian c/o Protagenic Therapeutics, Inc. 149 5th Avenue, Suite 500 New York NY NEW YORK 10010 Director Robert Ziroyan c/o Protagenic Therapeutics, Inc. 149 5th Avenue, Suite 500 New York NY NEW YORK 10010 Executive Officer Biotechnology Decline to Disclose 06b false 2013-02-15 false true false 0 642789 642789 0 false 5 0 0 0 false Protagenic Therapeutics Inc. /s/ Robert Ziroyan Robert Ziroyan Interim President and Chief Operating Officer 2013-09-26